- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01738126
fMRI and DTI of Cerebellar Responses to Pain in the Human Trigeminal System
This K01 application is designed to prepare the applicant with the skills necessary to establish an independent research program on pain--related processing in the cerebellum. Although pain studies using functional imaging in humans consistently find cerebellar activation, the role of this structure during pain is unknown. In such studies, speculation regarding the cerebellum's function during a painful event is often influenced by its reputation as a coordinator of motor function, though animal studies have indicated that it may also modulate the neural encoding of noxious stimuli. The candidate has published work that indicates a functional dichotomy in the way the cerebellum responds to experimental pain in healthy subjects and neuropathic pain patients. This suggests that the cerebellum has been overlooked as a potential pain processing area, and research into this area could lend invaluable insight into the basic physiological circuitry involved with pain and its modulation.
The hypothesis of this project is that the cerebellum serves as an integrator of aversive stimuli and adaptive motor behavior, and may modulate the emotional and cognitive experience that distinguishes the perception of pain from the appreciation of innocuous sensory stimulation. A human trigeminal model of experimental pain will be used, as all the pain---related circuitry involved can be imaged along with the cerebellum at the same time. The specific aims are (1) to map cerebellar activations related to sensory coding of noxious stimuli and to correlate functional activity with anatomical connectivity using functional magnetic resonance imaging (fMRI) and diffusion tensor imaging (DTI); (2) to distinguish between pain and its anticipation based on cerebellar responses and connectivity; and (3) to determine whether physical pain and aversive images engage similar circuitry in the cerebellum. To accomplish these aims, the candidate will need to expand his background in fMRI of cortical and brainstem pain processing to encompass cerebellar physiology, become proficient in DTI analysis, and learn the white matter connectivity to and from the cerebellum. The research environment at McLean Hospital and the other affiliates of the Harvard Medical School system will provide the candidate with the resources to reach his aims within 4 years.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Right-handed subjects
- Good physical health
- No history of claustrophobia
- English speaking and reading ability sufficient to comprehend consent without assistance
Exclusion Criteria:
- History of drug abuse or positive drug screen
- Magnetic Implants of any type (including dental bridges, crowns, retainers, orthodontic devices, etc)
- Weight > 285 pounds (weight limit of the fMRI table)
- Positive pregnancy screen
- Beck Depression Inventory II (BDI-II) score > 25 (moderate to severe depression)
- History of primary depression, anxiety disorders, or mood disorders
- Prolonged use of antidepressants or anticonvulsants
- Evidence of local pathology; e.g. cancer affecting the face
- History of systemic disorders, e.g. multiple sclerosis
- History of chronic pain, e.g. back pain
- History of primary headache, e.g. migraine, tension-type headache
- Recent orofacial surgery or trauma
- History of central origin disorders, eg. stroke
- History of dermatological hypersensitivity in the facial area
- History of Eczema
- Significant medical history of seizure disorder, diabetes, cardiac disease including coronary artery disease, psychiatric problems; respiratory problems, liver disease, etc.
- Significant alcohol history (ingestion of 5 or more glasses (>40 oz) of alcohol per week)
- Claustrophobia
- Pregnancy
- Smokers
- Tattoos containing metallic ink on the neck, shoulders, upper arm and head (which could become heated up in the scanner, and potentially cause blistering or burning)
- Cardiac pacemakers
- Aneurysm clips and other vascular stents, filters, clips or other devices
- Prosthetic heart valves
- Other prostheses
- Neuro-stimulator devices
- Implanted infusion pumps
- Cochlear (ear) implants
- Ocular (eye) implants or known metal fragments in eyes
- Exposure to shrapnel or metal filings (sheet metal workers, welders, and others)
- Other metallic surgical hardware in vital areas
- Repeated monthly usage of the ovulation test kit fails to detect a luteinizing hormone surge (for females not on contraception only)
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Whole brain functional magnetic resonance imaging (fMRI) data
Time Frame: 1 year
|
fMRI data is used to indirectly measure neurophysiological responses in the brain using the blood oxygen level dependent (BOLD) signal.
|
1 year
|
Pain ratings
Time Frame: 1 year
|
Subjective pain ratings elicited by experimental stimuli.
|
1 year
|
Whole-brain diffusion tensor imaging (DTI) data
Time Frame: 1 year
|
DTI data measures the integrity of white matter tracts in the brain, based on principles of water diffusion.
|
1 year
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- NIH-K01DA025289
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cerebellum and Pain in Healthy Volunteers.
-
Universidad Rey Juan CarlosCompletedPain Processing in Healthy VolunteersSpain
-
Xencor, Inc.ICON Clinical ResearchCompletedSafety in Healthy VolunteersUnited States
-
University of FloridaCompletedSatiety in Healthy VolunteersUnited States
-
Daiichi Sankyo, Inc.CompletedPharmacokinetics in Healthy VolunteersUnited States
-
University Medicine GreifswaldNot yet recruitingPharmacokinetic Study in Healthy VolunteersGermany
-
University Medicine GreifswaldRecruitingPharmacokinetic Study in Healthy VolunteersGermany
-
Medline IndustriesCompleted
-
Presidio Pharmaceuticals, Inc.CompletedPharmacokinetic Assessments in Healthy VolunteersUnited States
-
University Medicine GreifswaldCompletedImpact of OCT1 and CYP2D6 Genotypes on Pharmacokinetics of Berberine in Healthy Volunteers (BERKI-1)Pharmacokinetic Study in Healthy VolunteersGermany
-
Medicines Development for Global HealthCompletedQT Effects in Healthy VolunteersUnited States